IP Library Granted Patent US 9,677,103
Granted Patent B2
US 9,677,103 · App. 13/966,600 · Granted Jun 13, 2017

Expression system

Inventors: Bhupendra Vallabh Kara (Billingham, GB); Christopher David John Lennon (Billingham, GB); Ian John Hodgson (Billingham, GB)
Assignee: Fujifilm Diosynth Biotechnologies UK Limited
C12P21/00C12N15/70C12N15/72C12N15/73C12N15/78C12N15/81C12N15/85C12R1/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,677,103
App. No.
13/966,600
Granted
Jun 13, 2017
Kind
B2
Abstract

A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.

Claims (28)

1. A perfect palindrome operator sequence-based recombinant protein expression system for expression of proteins in prokaryotic cells comprising:

(a) an E. coli polymerase-dependent T7A3 promoter; and

(b) two or more perfect palindrome operator sequences, at least one operator sequence being located downstream of the promoter, and at least one operator sequence being located upstream of the promoter;

wherein:

the operator sequence upstream of the promoter and the operator sequence downstream of the promoter are spaced from 85 to 150 base pairs apart, and

an operator sequence overlaps the transcriptional start point.

2. An expression system according to claim 1 , wherein the operator sequences are spaced 91 or 92 base pairs apart.

3. A plasmid for expression of proteins in prokaryotic cells comprising:

(a) an E. coli polymerase-dependent T7A3 promoter; and

(b) two or more perfect palindrome operator sequences, at least one operator sequence being located downstream of the promoter, and at least one operator sequence being located upstream of the promoter;

wherein the operator sequence upstream of the promoter and the operator sequence downstream of the promoter are spaced from 85 to 150 base pairs apart.

4. A plasmid according to claim 3 , further comprising an expression cassette for a protein.

5. A plasmid according to claim 3 , wherein the operator sequences are spaced 91 or 92 base pairs apart.

6. A host cell transformed by a plasmid of claim 4 .

7. A host cell according to claim 6 , wherein the host cell is E. coli.

8. A method for the production of a recombinant protein in a prokaryotic cell which comprises expressing an expression system comprising

(a) an E. coli polymerase-dependent T7A3 promoter;

(b) two or more perfect palindrome operator sequences, at least one operator sequence being located downstream of the promoter, and at least one operator sequence being located upstream of the promoter; and

(c) an expression cassette for a recombinant protein,

wherein the operator sequence upstream of the promoter and the operator sequence downstream of the promoter are spaced from 85 to 150 base pairs apart, and

an operator sequence overlaps the transcriptional start point.

9. A method according to claim 8 , wherein the operator sequences are spaced 91 or 92 base pairs apart.

10. A method for producing a protein, which comprises:

(a) culturing a host cell transformed with a plasmid of claim 4 ; and

(b) recovering the protein.

11. A method according to claim 10 , wherein the host cell is E. coli.

12. A method according to claim 1 , wherein said two or more perfect palindrome operator sequences are lac or gal operator sequences.

13. A method according to claim 1 , wherein said two or more perfect palindrome operator sequences are lac operator sequences.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2016
From: KARA, BHUPENDRA VALLABH; LENNON, CHRISTOPHER DAVID JOHN; HODGSON, IAN JOHN
To: AVECIA BIOLOGICS LIMITED
Reel/Frame 039005/0770 →
CHANGE OF NAME Recorded Jun 24, 2016
From: AVECIA BIOLOGICS LIMITED
To: MSD BIOLOGICS (UK) LIMITED
Reel/Frame 039005/0834 →
CHANGE OF NAME Recorded Jun 24, 2016
From: MSD BIOLOGICS (UK) LIMITED
To: FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED
Reel/Frame 039005/0853 →
Priority Claims (1)
GB 0602173.7 · Feb 3, 2006 · national
Continuity (2)
Continuation 12223527
Related Publication 20140065670A1 · Mar 6, 2014